Unknown

Dataset Information

0

Structural basis for allosteric PARP-1 retention on DNA breaks.


ABSTRACT: The success of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors (PARPi) to treat cancer relates to their ability to trap PARP-1 at the site of a DNA break. Although different forms of PARPi all target the catalytic center of the enzyme, they have variable abilities to trap PARP-1. We found that several structurally distinct PARPi drive PARP-1 allostery to promote release from a DNA break. Other inhibitors drive allostery to retain PARP-1 on a DNA break. Further, we generated a new PARPi compound, converting an allosteric pro-release compound to a pro-retention compound and increasing its ability to kill cancer cells. These developments are pertinent to clinical applications where PARP-1 trapping is either desirable or undesirable.

SUBMITTER: Zandarashvili L 

PROVIDER: S-EPMC7347020 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4678113 | biostudies-literature
| S-EPMC4081085 | biostudies-literature
| S-EPMC5175350 | biostudies-literature
| S-EPMC1809751 | biostudies-literature
| S-EPMC3532513 | biostudies-literature
| S-EPMC10066190 | biostudies-literature
| S-EPMC7515732 | biostudies-literature
| S-EPMC9451145 | biostudies-literature
| S-EPMC6796912 | biostudies-literature
| S-EPMC4161293 | biostudies-literature